By the end of the year, three quarters of the world’s prescription medicines will fall under track and trace legislation aimed at preserving supply chain integrity. Colin Newbould, director of regulatory affairs and QP services at the Wasdell Group, discusses upcoming deadlines and what companies should be thinking about as the scope and requirements of track and trace legislation continue to change.
Future proof
A shifting landscape